These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31866289)

  • 1. The role of transglutaminase 2 in mediating glial cell function and pathophysiology in the central nervous system.
    Rudlong J; Cheng A; Johnson GVW
    Anal Biochem; 2020 Feb; 591():113556. PubMed ID: 31866289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of astrocytic transglutaminase 2 improves injury outcomes.
    Monteagudo A; Feola J; Natola H; Ji C; Pröschel C; Johnson GVW
    Mol Cell Neurosci; 2018 Oct; 92():128-136. PubMed ID: 29969654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition or ablation of transglutaminase 2 impairs astrocyte migration.
    Monteagudo A; Ji C; Akbar A; Keillor JW; Johnson GVW
    Biochem Biophys Res Commun; 2017 Jan; 482(4):942-947. PubMed ID: 27899316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.
    Quinn BR; Yunes-Medina L; Johnson GVW
    J Neurosci Res; 2018 Jul; 96(7):1150-1158. PubMed ID: 29570839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transglutaminase type 2 affects cell migration through post-translational modification of platelet-derived growth factor-BB.
    Cordella M; Tabolacci C; Rossi S; Senatore C; Facchiano AM; D'Arcangelo D; Facchiano A; Facchiano F
    Amino Acids; 2017 Mar; 49(3):473-481. PubMed ID: 27633721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gα(h)/transglutaminase-2 activity is required for maximal activation of adenylylcyclase 8 in human and rat glioma cells.
    Obara Y; Yanagihata Y; Abe T; Dafik L; Ishii K; Nakahata N
    Cell Signal; 2013 Mar; 25(3):589-97. PubMed ID: 23200849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcellular localization patterns of transglutaminase 2 in astrocytes and neurons are differentially altered by hypoxia.
    Yunes-Medina L; Feola J; Johnson GVW
    Neuroreport; 2017 Dec; 28(18):1208-1214. PubMed ID: 28957946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transglutaminase 2 modulation of NF-κB signaling in astrocytes is independent of its ability to mediate astrocytic viability in ischemic injury.
    Feola J; Barton A; Akbar A; Keillor J; Johnson GVW
    Brain Res; 2017 Aug; 1668():1-11. PubMed ID: 28522262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological Implications and Functional Significance of Transglutaminase Type 2 in Nervous System Tumors.
    Buccarelli M; Castellani G; Fiorentino V; Pizzimenti C; Beninati S; Ricci-Vitiani L; Scattoni ML; Mischiati C; Facchiano F; Tabolacci C
    Cells; 2024 Apr; 13(8):. PubMed ID: 38667282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue transglutaminase activity is involved in the differentiation of oligodendrocyte precursor cells into myelin-forming oligodendrocytes during CNS remyelination.
    Van Strien ME; Baron W; Bakker EN; Bauer J; Bol JG; Brevé JJ; Binnekade R; Van Der Laarse WJ; Drukarch B; Van Dam AM
    Glia; 2011 Nov; 59(11):1622-34. PubMed ID: 21818782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue transglutaminase in astrocytes is enhanced by inflammatory mediators and is involved in the formation of fibronectin fibril-like structures.
    Espitia Pinzón N; Brevé JJP; Bol JGJM; Drukarch B; Baron W; van Dam AM
    J Neuroinflammation; 2017 Dec; 14(1):260. PubMed ID: 29282083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of Transglutaminase 2 from Mouse Astrocytes Significantly Improves Their Ability to Promote Neurite Outgrowth on an Inhibitory Matrix.
    Emerson J; Delgado T; Girardi P; Johnson GVW
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments.
    Park D; Choi SS; Ha KS
    Amino Acids; 2010 Aug; 39(3):619-31. PubMed ID: 20148342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
    van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
    Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the minimum domain of the fibronectin binding site on transglutaminase 2 (TG2) and its importance in mediating signaling, adhesion, and migration in TG2-expressing cells.
    Soluri MF; Boccafoschi F; Cotella D; Moro L; Forestieri G; Autiero I; Cavallo L; Oliva R; Griffin M; Wang Z; Santoro C; Sblattero D
    FASEB J; 2019 Feb; 33(2):2327-2342. PubMed ID: 30285580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transglutaminase 2 in the balance of cell death and survival.
    Fésüs L; Szondy Z
    FEBS Lett; 2005 Jun; 579(15):3297-302. PubMed ID: 15943974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polydendrocytes--their roles in development and glial tumor formation].
    Suzuki R; Nishiyama A
    Brain Nerve; 2009 Jul; 61(7):733-9. PubMed ID: 19618850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase is a tumor cell and cancer stem cell survival factor.
    Eckert RL; Fisher ML; Grun D; Adhikary G; Xu W; Kerr C
    Mol Carcinog; 2015 Oct; 54(10):947-58. PubMed ID: 26258961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of transglutaminase 2 from astrocytes significantly improves their ability to promote neurite outgrowth on an inhibitory matrix.
    Emerson J; Delgado T; Girardi P; Johnson GV
    bioRxiv; 2023 Feb; ():. PubMed ID: 36798305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 2 on the surface of dendritic cells is proposed to be involved in dendritic cell-T cell interaction.
    Kim JH; Jeong EM; Jeong YJ; Lee WJ; Kang JS; Kim IG; Hwang YI
    Cell Immunol; 2014; 289(1-2):55-62. PubMed ID: 24727157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.